SAN RAFAEL, Calif., Oct. 11, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that Forbes' named the company to its list, Global 2000: World's Best Employers. It is ranked within the top 300 out of a total of 2000 companies and fifth among the nine biotech companies also named. This marks the second time this year that BioMarin has been acknowledged as a top place to work by Forbes, having also been named to the magazine's list of Best Mid-Sized Employers, earlier this year with a ranking of 51 among 500 companies and third among biotech companies also named.
"BioMarin is a pioneer in developing treatments for rare disease, which requires a level of comfort in encountering the unknown. People who are attracted to BioMarin are energized by the challenge of doing what has never been done before scientifically and by the potential to change the course of a disease," said Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin. "We are honored to be acknowledged by Forbes as a top employer. We work hard to create a collaborative and scientifically-curious work environment that draws people who are passionate and committed to making a big difference for small patient populations."
In addition to the company's debut on the list of World's Best Employers and its recognition as one of "America's Best Mid-size Employers," BioMarin has also appeared on the magazine's "Most Innovative Companies" list four years in a row where it was ranked in the top 12 each year.
To view the complete list of World's Best Employers, click here.
Methodology The Forbes list of World's Best Employers is based on Forbes' 2018 Global 2000 rankings, which included publicly traded companies from 60 countries that together accounted for $39.1 trillion in sales, $3.2 trillion in profit, $189 trillion in assets and $56.8 trillion in market value.
More than 430,000 global recommendations were analyzed by Statista to create the World's Best Employers list. Employees were asked to rate their own employer and the likelihood they would recommend the company to a friend or family member. They were also asked to recommend other employers they admired.
About BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com.
BioMarin® is a registered trademark of BioMarin Pharmaceutical Inc. and its affiliates.